The Big Idea Podcast

Welcome to The Ed Clay Show hosted by Ed Clay in Nashville, TN. 

As the Nashville Mayoral election approaches on August 3rd, we wanted to take the time to interview a handful of the candidates to give our viewers in Nashville the opportunity to learn more about the platforms being proposed for our city.

Today we are joined by Alice Rolli, a Nashville native running for Mayor of Nashville in the 2023 election. We discuss her plans to address the city's housing crisis, the importance of education, and the necessary improvements to the city's infrastructure.

Alice believes strongly in the power of quality education to change lives and communities. She shares her goals to invest in Nashville's schools and teachers, and her commitment to ensuring that every child in Nashville has access to a high-quality education.

Learn more about Alice on her website: www.alicerolli.com

If you gained some valuable insight from the show, share it with your friends!

Follow The Ed Clay Show on Instagram at  @EdClayShow   

#TheEdClayShow #EdClay #NashvilleTN #EdClayPodcast #NashvilleMayoralRace #AliceRolli

Timestamps:
0:00:00 Intro
0:01:30 Introduction and background
0:04:00 Motivation to run for Mayor
0:07:00 Discussion on early career and experiences
0:10:00 Perspective on the current state of Nashville
0:13:00 Vision for Nashville's future
0:16:00 Stance on education and school system
0:19:00 Plans for economic development
0:22:00 Views on Nashville's housing issues
0:25:00 Approach to healthcare and public services
0:28:00 Thoughts on Nashville's infrastructure
0:31:00 Plans for public safety
0:34:00 Stance on environmental issues and sustainability
0:37:00 Views on the role of technology in governance
0:40:00 Thoughts on the importance of community engagement
0:43:00 Plans for improving public transportation
0:46:00 Approach to dealing with Nashville's growth
0:49:00 Thoughts on the importance of diversity and inclusion
0:52:00 Views on the role of arts and culture in Nashville
0:55:00 Perspective on the challenges facing Nashville
1:01:00 Discussion on the importance of local businesses
1:04:00 Views on the role of youth in Nashville's future
1:07:00 Final thoughts and closing remarks

In this episode of The Big Idea, Ed talks with lifelong friend and Nashville-based artist Jellyroll about his long road to success, how Covid-19 has affected the music business, and ways to stand up for racial equality. 

In this episode of The Big Idea Podcast, Dr. Francesco Marincola MD, former Chief of Infectious disease and Immunogenetics for the National Institute of Health, takes us through his career as one of the world’s leading experts in cancer immunotherapy. He discusses the history of immunotherapy for cancer from the 1980’s to now and what he sees as the future of cancer treatment for patients.

Coronavirus Testing Explained by Leading Geneticist and Diagnostics Expert

Dr. Vijay Mahant is a renowned scientist and co founder of Auto Genomics, Medi-Lite and Qualigen. Dr. Mahant’s work can be seen all over the world in leading cancer institutions using his cutting edge genetic and diagnostic equipment. He has been on the forefront of the liquid biopsy and circulating tumor cell movement. His passion is to find ways to match tumors with specific drugs that might be off label and to create even better early detection diagnostic tests. In this interview he explains COVID-19 testing and how it works.

Stem Cell Treatment for Covid-19

Stem Cells have been used to treat various health conditions and it is now being used to treat coronavirus patients. In this video, Alex Spinoso, a medical doctor from Las Vegas Nevada, talks about how he is working on stem cell treatments for Covid-19 and other ailments.

CRISPR and CAR T-Cells for Cancer: Dr. Bing Wang Explains Company's Innovative Approach and More

In this interview, Dr. Wang talks about his company's unique technology that merges CRISPR and CAR T-Cells For treatment in solid tumor cancers. Also, how the coronavirus pandemic is affecting the biotech community.

Dr. Wang is CEO of Refuge, a company he co-founded following nearly a decade of life science investment banking experience. He most recently served as director of healthcare investment banking at Barclays Capital, where he served as strategic financial advisor and helped raised capital for companies in the healthcare industry. Dr. Wang, a cancer survivor who is passionate about bringing forth “smarter” medicines that will transform cancer care, earned a B.S. in Applied Physics from Columbia University, an MBA from Columbia Business School, and a Ph.D. in Electrical Engineering from Princeton University.

Coronavirus Patients in Italy Treated with Ozone Therapy

The coronavirus in Italy has become one of the hot spots for Covid-19 outbreaks in the word. There are many treatments for coronavirus, but this one is a unique approach that is being done in Italy by Dr. Amato De Monte, Director of the Asufc Department of Anesthesia and Resuscitation at the Hospital of Udin . In this interview he talks about Ozone Therapy and how he is using it as a treatment for COVID-19 patients in Italy.

Dominick Cruz Highlights Coronavirus Fears

Dominick Cruz highlights the coronavirus and how to overcome fear. He Teaches How to Use The Fighters Mindset to OVERCOME Your Personal Covid19 Battle and explains How to Use FEAR as an Advantage by Just SURRENDERING to it.

The Coronavirus: Response vs Reaction

Covid-19, or the Coronavirus, has brought a lot of stress to people around the world. People have lost their jobs and their businesses and some people are struggling to put food on the table for their families. Everyone is experiencing their own stress from the corona virus. In this video, CHIPSA Hospital Founder & Martial Arts Legend, Scott Nelson Explains Why Responding is better than Reacting to Coronavirus stress.

Dr. Michael Liebman is a leading expert serving on 14 scientific advisory boards. He is working on mathatical models to predict where Coronavirus cases will end up next. (Make sure to read his bio at the bottom)

Find out in this podcast:

- The current mortality rate in the U.S. and worldwide(It's lower than the headlines)

- Why it's counterproductive to panic
- How many people have been tested and why there's been a hold up
- Ways you can limit you and your families risk
- How it's transmitted
- The most vulnerable population
- The best possible outcome in the United States

and more...

Don't just read the headlines get fully informed!

Michael N. Liebman, Ph.D. is the Managing Director of IPQ Analytics, LLC and of Strategic Medicine, Inc, and Strategic Medicine, BV (the Hague, NL) after serving as the Executive Director of the Windber Research Institute from 2003-2007. He is also an Adjunct Professor of Pharmacology and Physiology at Drexel College of Medicine and Adjunct Professor of Drug Discovery, First Hospital of Wenzhou Medical University. Previously, he was Director, Computational Biology and Biomedical Informatics at the University of Pennsylvania Cancer Center 2000-2003.

He served as Global Head of Computational Genomics at Roche Pharmaceuticals and Director, Bioinformatics and Pharmacogenomics at Wyeth Pharmaceuticals, Director of Genomics for Vysis, Inc. He is a co-founder of Prosanos, Inc (now United BioSource) (2000). He was on the faculty of Mount Sinai School of Medicine in Pharmacology and Physiology/Biophysics.

He serves on 14 scientific advisory boards and is on the Board of Directors and chairs the Science Committee of the Nathaniel Adamczyk Foundation for Pediatric ARDS and is an Advisor to the American Heart Association Science and Technology Accelerator. Michael is Chair of the Informatics Program of the PhRMA Foundation and also Chair of its new program in Translational Medicine and Therapeutics and is a member of the PhRMA Scientific Advisory Board. He is on the Advisory Board of the International Society for Translational Medicine and on the Editorial Board for the Journal of Translational Medicine, for Clinical and Translational Medicine and for Molecular Medicine and Therapeutics and the International Park for Translational Biomedicine (Shanghai). He is an Invited Professor at the Shanghai Center for Bioinformatics Technology.

His research focuses on computational models of disease progression stressing risk detection, disease process and pathway modeling and analysis of lifestyle interactions and causal biomarker discovery and focuses on moving bedside problems into the research laboratory to improve patient care and quality of life. Recent activities also include computational approaches to disease modeling, patient and disease stratification, drug safety, reduction of animal testing, the use of genomic data in healthcare, and both qualitative and quantitative risk assessment in health care and the life sciences.